OC-001 for Advanced Cancers
Recruiting1 awardPhase 1 & 2
Edmonton, Alberta
This trial is testing a new treatment called OC-001, both by itself and with other drugs that help the immune system fight cancer. It aims to help patients with various types of cancer by making their immune system better at attacking cancer cells.
CAR T-cell Therapy
TIL Therapy for Advanced Cancer
Recruiting1 awardPhase 2
Pittsburgh, Pennsylvania
This trial tests a treatment for advanced cancers that haven't responded to standard treatments. It involves reducing the patient's immune cells, then using their own enhanced immune cells to fight the cancer, supported by a drug that boosts immune activity.
Checkpoint Inhibitor
Immunotherapy + Tacrolimus for Cancer in Kidney Transplant Recipients
Recruiting1 awardPhase 1
Tampa, Florida
This trialstudies a combo of drugs to treat kidney transplant recipients' cancer that can't be surgically removed or has spread. Immunotherapy & tacrolimus may help attack the cancer & stop tumor growth. It may work better than surgery, chemo, radiation or targeted therapies.
PD-1/PD-L1 Checkpoint Inhibitor
Combination Immunotherapy for Cancer
Recruiting1 awardPhase 2
Hot Springs, Arkansas
This trial tests a combination of treatments that aim to boost the immune system in patients whose cancer has progressed after previous treatments. Some patients may receive an additional therapy if their disease continues to progress.
Popular Filters
Trials for Neuroendocrine Carcinoma Patients
Radiation Therapy
Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
Recruiting1 awardPhase 2
Houston, Texas
This trial will test if it is just as effective to give a higher dose of radiation in 10 treatments as it is to give a lower dose of radiation in 25 treatments for Merkel cell carcinoma patients receiving immunotherapy.
Topoisomerase I inhibitor
FF-10850 Topotecan Liposome Injection for Solid Tumors
Recruiting1 awardPhase 1
Scottsdale, Arizona
This trial tests a new form of a cancer drug called topotecan, which is packed in tiny fat bubbles to make it work better and be safer. It targets patients with advanced ovarian cancer and Merkel cell carcinoma who need new treatment options. The drug stops cancer cells from growing by attacking their DNA.
Trials for NEC Patients
Radiation Therapy
Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
Recruiting1 awardPhase 2
Houston, Texas
This trial will test if it is just as effective to give a higher dose of radiation in 10 treatments as it is to give a lower dose of radiation in 25 treatments for Merkel cell carcinoma patients receiving immunotherapy.
Topoisomerase I inhibitor
FF-10850 Topotecan Liposome Injection for Solid Tumors
Recruiting1 awardPhase 1
Scottsdale, Arizona
This trial tests a new form of a cancer drug called topotecan, which is packed in tiny fat bubbles to make it work better and be safer. It targets patients with advanced ovarian cancer and Merkel cell carcinoma who need new treatment options. The drug stops cancer cells from growing by attacking their DNA.
Trials for Metastatic Patients
Topoisomerase I inhibitor
FF-10850 Topotecan Liposome Injection for Solid Tumors
Recruiting1 awardPhase 1
Scottsdale, Arizona
This trial tests a new form of a cancer drug called topotecan, which is packed in tiny fat bubbles to make it work better and be safer. It targets patients with advanced ovarian cancer and Merkel cell carcinoma who need new treatment options. The drug stops cancer cells from growing by attacking their DNA.
Small Molecule Inhibitor
Navtemadlin +/− Immunotherapy for Skin Cancer
Recruiting1 awardPhase 1 & 2
Aurora, Colorado
This trial is testing a new drug to treat Merkel cell carcinoma, a type of skin cancer. The drug works by targeting a protein called MDM2. Previous treatments haven't worked for patients with this cancer, so this trial is testing to see if this new drug is effective.
Checkpoint Inhibitor
Immunotherapy + Radiation for Cancer
Recruiting1 awardPhase 2
Anchorage, Alaska
This trial is studying two different ways to give pembrolizumab (with or without stereotactic body radiation therapy) to see how well it works in treating patients with Merkel cell cancer that has spread to other places in the body.
Trials With No Placebo
Radiation Therapy
Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
Recruiting1 awardPhase 2
Houston, Texas
This trial will test if it is just as effective to give a higher dose of radiation in 10 treatments as it is to give a lower dose of radiation in 25 treatments for Merkel cell carcinoma patients receiving immunotherapy.
Topoisomerase I inhibitor
FF-10850 Topotecan Liposome Injection for Solid Tumors
Recruiting1 awardPhase 1
Scottsdale, Arizona
This trial tests a new form of a cancer drug called topotecan, which is packed in tiny fat bubbles to make it work better and be safer. It targets patients with advanced ovarian cancer and Merkel cell carcinoma who need new treatment options. The drug stops cancer cells from growing by attacking their DNA.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.